Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Fenaux

Showing results (31-40 of 432) with videos related to

Pageof 44
Sort By:
Best Practice & Research. Clinical Haematology|August 26, 2003
Treatment of older adults with acute promyelocytic leukaemiaPierre Fenaux, Sylvie Chevret, Stéphane de Botton
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Haematologica|September 13, 2005
Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidenceMiguel A Sanz, Pierre Fenaux, Francesco Lo Coco, et al.
Oncology Research|February 24, 2004
Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cell linePauline Huyghe, Laurent Dassonneville, Pierre Fenaux, et al.
Expert Opinion on Drug Safety|November 10, 2011
The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromesAntonio Palumbo, John Freeman, Lilia Weiss, et al.
Haematologica|June 27, 2012
Infections in myelodysplastic syndromesAndréa Toma, Pierre Fenaux, François Dreyfus, et al.
Best Practice & Research. Clinical Haematology|February 11, 2014
Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?Raphael Itzykson, Raphael Itzkson, Pierre Fenaux, et al.
Biomedicines|May 16, 2023
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid LeukemiaRamy Rahmé, Thorsten Braun, James J Manfredi, et al.
Haematologica|February 5, 2008
Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomideVirginie Eclache, Anna Da Rocha, Génevieve Le Roux, et al.
Annals of Hematology|February 18, 2011
A European survey on the detection and management of iron overload in transfusion-dependent patients with MDSAristoteles Giagounidis, Susanna Leto di Priolo, Susanne Ille, et al.
Pageof 44

Showing results (31-40 of 432) with videos related to

Sort By:
Pageof 44
Best Practice & Research. Clinical Haematology|August 26, 2003
Treatment of older adults with acute promyelocytic leukaemiaPierre Fenaux, Sylvie Chevret, Stéphane de Botton
Blood|January 4, 2019
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisPierre Fenaux, Jean Jacques Kiladjian, Uwe Platzbecker
Haematologica|September 13, 2005
Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidenceMiguel A Sanz, Pierre Fenaux, Francesco Lo Coco, et al.
Oncology Research|February 24, 2004
Hydroxyurea-induced apoptosis in an EBV-immortalized lymphoblastoid cell linePauline Huyghe, Laurent Dassonneville, Pierre Fenaux, et al.
Expert Opinion on Drug Safety|November 10, 2011
The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromesAntonio Palumbo, John Freeman, Lilia Weiss, et al.
Haematologica|June 27, 2012
Infections in myelodysplastic syndromesAndréa Toma, Pierre Fenaux, François Dreyfus, et al.
Best Practice & Research. Clinical Haematology|February 11, 2014
Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?Raphael Itzykson, Raphael Itzkson, Pierre Fenaux, et al.
Biomedicines|May 16, 2023
TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid LeukemiaRamy Rahmé, Thorsten Braun, James J Manfredi, et al.
Haematologica|February 5, 2008
Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomideVirginie Eclache, Anna Da Rocha, Génevieve Le Roux, et al.
Annals of Hematology|February 18, 2011
A European survey on the detection and management of iron overload in transfusion-dependent patients with MDSAristoteles Giagounidis, Susanna Leto di Priolo, Susanne Ille, et al.
Pageof 44